Kenji Ichiyama Selected Research

ascorbic acid 2-sulfate

10/2007

Inhibition of free radical-induced erythrocyte hemolysis by 2-O-substituted ascorbic acid derivatives.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenji Ichiyama Research Topics

Disease

4	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 08/2007
1	Neoplasms (Cancer) 01/2019
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2016
1	Asthma (Bronchial Asthma) 09/2013
1	Inflammation (Inflammations) 06/2008
1	Hypersensitivity (Allergy) 05/2008
1	Hemolysis 10/2007
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2007
1	Lupus Nephritis 08/2007

Drug/Important Bio-Agent (IBA)

1	MicroRNAs (MicroRNA)IBA 01/2019
1	EndoribonucleasesIBA 01/2016
1	CytokinesIBA 04/2015
1	Interleukin-9 (Interleukin 9)IBA 09/2013
1	Vitamin D FDA LinkGeneric 09/2011
1	Interleukin-17 (Interleukin 17)IBA 09/2011
1	InterleukinsIBA 06/2008
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 06/2008
1	Interleukin-4 (Interleukin 4)IBA 05/2008
1	ascorbic acid 2-sulfateIBA 10/2007
1	Free RadicalsIBA 10/2007
1	perhydroxyl radicalIBA 10/2007
1	2,2'-azobis(2-amidinopropane) (ABAP)IBA 10/2007
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2007
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 10/2007
1	ascorbate-2-phosphateIBA 10/2007
1	AntioxidantsIBA 10/2007
1	ascorbic acid 2-O-glucosideIBA 10/2007
1	AutoantibodiesIBA 08/2007